Shares of Synairgen plc (LON:SNG – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 6.03 ($0.08) and traded as low as GBX 5.33 ($0.07). Synairgen shares last traded at GBX 5.39 ($0.07), with a volume of 377,125 shares trading hands.
Synairgen Price Performance
The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The company has a fifty day moving average price of GBX 6.39 and a 200 day moving average price of GBX 6.03. The company has a market capitalization of £11.40 million, a P/E ratio of -111.20 and a beta of -2.23.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- What is Short Interest? How to Use It
- Gilead Sciences Stock Surges on HIV Treatment Trial Success
- Breakout Stocks: What They Are and How to Identify Them
- Dell and Super Micro Computer: Musk’s Favorite AI Hardware Stocks
- Dividend Capture Strategy: What You Need to Know
- Top 3 Home Builder Stocks: Key Insights into the Housing Market
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.